Filing Details
- Accession Number:
- 0001209191-14-003318
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-15 16:35:56
- Reporting Period:
- 2014-01-14
- Filing Date:
- 2014-01-15
- Accepted Time:
- 2014-01-15 16:35:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1044831 | S Darryl Baker | 444 South Ellis Street Chandler AZ 85224 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-14 | 5,000 | $3.54 | 8,125 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-14 | 5,000 | $47.07 | 3,125 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-01-15 | 5,000 | $3.54 | 8,125 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-15 | 5,000 | $48.01 | 3,125 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-14 | 5,000 | $0.00 | 5,000 | $3.54 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-15 | 5,000 | $0.00 | 5,000 | $3.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
55,000 | 2022-12-27 | No | 4 | M | Direct | |
50,000 | 2022-12-27 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2013
- The option vests in 36 equal monthly installments measured from the grant date of December 27, 2012 and will be fully vested and exercisable on December 27, 2015.